Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid Syndrome

DOAC Versus VKA in Patients With Non-high-risk APS : Prospective Cohort Study

NCT06884384 ·Status: NOT_YET_RECRUITING

Causes and Prevention of Thromboembolic Disease in Nephrotic Syndrome

NCT04850378 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants

NCT04262492 ·Status: RECRUITING

Study on Antithrombotic Prevention in Thrombophilia and Pregnancy Loss

NCT02385461 ·Status: UNKNOWN

Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome

NCT02295475 ·Status: COMPLETED ·Phase: PHASE4

Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT Study

NCT00252005 ·Status: COMPLETED ·Phase: PHASE2

COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis

NCT04650087 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Safety and Efficacy of Anticoagulation Treatment in Patients With Splanchnic Vein Thrombosis: SAPIENT Study

NCT06262750 ·Status: RECRUITING

Keeping Oral o Parental AnticoaguLation in the Acute Phase of Cardioembolic Ischemic Stroke

NCT05486351 ·Status: UNKNOWN

Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness

NCT00457002 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Effects of 2 Prothrombin Complex Concentrates on the Pharmacodynamics of Apixaban in Healthy Adult Subjects

NCT02074358 ·Status: COMPLETED ·Phase: PHASE1

A Nationwide Registry Study of Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation Therapies In The Early Period Following Apixaban Marketing In Denmark

NCT02591732 ·Status: COMPLETED

Coronavirus Disease (COvid-)19 REgistry on THROMBOSIS Complications

NCT04780295 ·Status: COMPLETED

Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events

NCT02155491 ·Status: COMPLETED

Registry of Patients Prescribed Anticoagulation

NCT03504007 ·Status: RECRUITING

Effectiveness of Interventions for Hospital Medical Thromboprophylaxis: a Bicentric Swiss Quality-improvement Study

NCT05306821 ·Status: UNKNOWN ·Phase: NA

Hydroxychloroquine for Thrombosis Prevention and Antiphospholipid Antibody Reduction in Primary Antiphospholipid Syndrome

NCT04153201 ·Status: COMPLETED ·Phase: NA

Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients

NCT02792335 ·Status: COMPLETED

AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients

NCT01780987 ·Status: COMPLETED ·Phase: PHASE3

Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection

NCT04651400 ·Status: COMPLETED

Efficacy and Safety of Low-molecular Weight Heparin for Thromboprophylaxis in Acutely Ill Medical Patients

NCT00311753 ·Status: COMPLETED ·Phase: PHASE3

AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia

NCT05848713 ·Status: RECRUITING ·Phase: PHASE3

Apixaban in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France

NCT02714855 ·Status: COMPLETED

Andexanet Alfa and 4F-PCC Use in Patients Hospitalised With an Anticoagulant-related Major Bleed

NCT05548777 ·Status: COMPLETED

Multicentric Prospective Validation of a Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and Fondaparinux Levels

NCT04539301 ·Status: RECRUITING